This trial will study the long-term effects of transcranial ultrasound on people with ADHD.
0 Primary · 1 Secondary · Reporting Duration: Post Final Treatment (8 weeks from baseline)
Experimental Treatment
100 Total Participants · 1 Treatment Group
Primary Treatment: Brainsonix Pulsar 1002 · No Placebo Group · N/A
Age 18 - 60 · All Participants · 4 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:California | 66.7% |
Illinois | 33.3% |
18 - 65 | 100.0% |
Neurological Associates of West LA | 75.0% |
Neurological Associates of West Los Angele | 25.0% |
Met criteria | 80.0% |
Did not meet criteria | 20.0% |